Viscodril

Quick links to important sections

Viscodril

Method of action: Antitussive

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Viscodril

Quick Facts

Property Description
Active Ingredients Diphenhydramine, Ammonium Chloride
Form Oral Solution (Syrup)
Pharmacological Class Antitussive-Expectorant Combination
General Purpose Symptomatic relief of cough and congestion
Origin Synthetic Chemical Combination

What Type of Medicine is Viscodril?

Viscodril is a combination medicine administered via the oral route and typically supplied as an oral solution or syrup. Pharmacologically, it is classified as an Antitussive-Expectorant Combination, containing agents designed both to suppress the cough reflex and to assist in clearing mucus from the airways. This dual functionality is clinically recognized as an effective strategy for managing symptomatic coughs. The formulation is a primarily synthetic therapeutic agent, positioned for patients seeking comprehensive relief from persistent coughs often associated with colds.


What is Viscodril Made Of? (Composition and Action)

The efficacy of Viscodril relies on the synergy between its two main active ingredients: Diphenhydramine and Ammonium Chloride. Diphenhydramine is a first-generation H1-receptor antihistamine that provides a central cough suppressant effect by calming the cough center in the brain. Meanwhile, Ammonium Chloride functions as a systemic expectorant. This expectorant component is supported by pharmacological studies confirming its ability to thin and loosen tenacious phlegm and mucus, making it easier to clear the chest. The medicine's overall benefit is defined by this combination: it controls the frequency of the cough reflex while simultaneously improving the overall productivity of a cough.

Regulatory References

  1. Cold and Cough Medicines - MedlinePlus

What side effects are possible with Viscodril?

Possible Side Effects and Safety Information

The safety profile for Viscodril, a combination medicine containing Diphenhydramine and Ammonium Chloride, is based on the adverse reactions and constraints documented by governmental regulatory authorities.

Adverse Reaction Scope

Category Description based on Official Regulatory Labels
Most Frequent Reactions The most frequently documented adverse reactions are associated with the Nervous System and include sedation, sleepiness, dizziness, and disturbed coordination.
System-Organ Classes Adverse reactions are officially categorized across various systems, including the Nervous System, Gastrointestinal System, Cardiovascular System, and Hematologic System.
Other Common Reactions Non-serious effects commonly listed include dryness of the mouth, nose, and throat, as well as various gastrointestinal disturbances like nausea and vomiting.

Serious Reactions and Safety Constraints

Regulatory documents list certain rare but serious adverse reactions, such as anaphylactic shock and severe hematologic reactions like hemolytic anemia. The medicine also carries a documented risk of severe metabolic acidosis or ammonia toxicity for patients with pre-existing conditions.

Population-Specific Safety Notes

The medicine is officially contraindicated for use in neonates, premature infants, and nursing mothers. Older adults are noted to be more susceptible to frequent adverse effects like sedation and hypotension. Caution is also specifically advised for individuals with conditions such as narrow-angle glaucoma, hypertension, or severe hepatic or renal impairment.


This structure reflects how regulatory safety information organizes the medicine's risk profile, highlighting the primary risk of CNS depression and defining specific patient populations and pre-existing medical conditions that require particular caution or restriction of use.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdosage of medicines containing diphenhydramine and ammonium chloride is documented to cause a wide range of clinical manifestations. Officially listed presentations may range from central nervous system (CNS) depression (e.g., severe drowsiness, confusion, coma) to CNS stimulation (e.g., agitation, delirium, and hallucinations). Other documented signs include tachycardia (rapid heartbeat), hypotension (low blood pressure), and anticholinergic effects such as dilated pupils and urinary retention. Overdose of the ammonium chloride component may lead to metabolic acidosis.

A severe overdose is associated with the risk of seizures, respiratory failure, and serious heart problems, including adverse cardiac rhythms, which are classified as potentially life-threatening outcomes. Overdose risk is noted in specific populations, with children being particularly susceptible to paradoxical stimulation and seizures, while the elderly are more prone to sedation and hypotension.

Immediate medical attention or contacting poison control is mandated if the affected person is experiencing a seizure, is unable to be awakened, is hallucinating, or is having trouble breathing, according to regulatory guidance. Treatment is primarily symptomatic and supportive, often involving activated charcoal or gastric lavage, and requires rigorous monitoring of vital signs and cardiac function, as no specific antidote is known.

Therapeutic Uses of Viscodril

What Viscodril Treats: Main Uses and Benefits

Viscodril is commonly used in acute episodes of upper respiratory illnesses, applied across domains where additional symptomatic support is needed to address the combined pattern of a disruptive cough and symptoms of chest congestion. It helps manage both the persistent, irritating cough and symptoms of viscous chest congestion, and is used for managing symptoms related to the presence of phlegm and mucus.

The medication is relevant for easing symptomatic discomfort due to a variety of conditions, including the common cold, upper respiratory tract infections, and certain allergic responses. It is also used for easing symptoms associated with hay fever or other upper respiratory allergies, including runny nose, sneezing, and itching of the nose or throat.

This combination for symptomatic support is often used when symptoms intensify and short-term supportive relief is needed, such as when coughing symptoms interfere with daily functioning, particularly at night. This symptomatic support helps maintain a sense of stability when symptoms are more noticeable.

“The primary goal of this supportive medication is to help ease the overall symptom burden and contributes to improved day-to-day comfort during periods of heightened symptoms.”


Quick Fact Area of Symptom Support
Dual Symptom Focus Persistent Cough and Viscous Chest Congestion
Key Patient Benefit Contributes to managing symptoms during acute illness phases
Target Context Nighttime disruption and acute cold/allergy clusters

Regulatory References

  1. NIH DailyMed label

Eligibility and Restrictions for Use

Who Can and Cannot Use Viscodril?

The population eligibility for using Viscodril, a combination of Diphenhydramine and Ammonium Chloride, is strictly defined by official regulatory labeling, establishing clear rules for use, restrictions, and contraindications.

Contraindicated Populations

Viscodril is contraindicated and must not be used by several groups, including nursing mothers and individuals with known hypersensitivity to either active ingredient. Official labeling strictly prohibits use in children younger than 2 years of age and in neonates or premature infants. Use is also prohibited for patients diagnosed with severe renal impairment or severe hepatic impairment.


Restricted and Conditional Use

Population Group Eligibility Status
Adults & Adolescents (12+) Generally permitted under standard labeled conditions.
Children (6 to 11 years) Restricted use; typically requires lower dosing and is subject to special regulatory guidance.
Older Adults (60+ years) Requires caution due to increased risk factors for sedation and other effects.
Pregnant Individuals Not recommended unless clearly necessary (Category B/C classification).

Official documents require caution for patients with pre-existing conditions such as narrow-angle glaucoma, prostatic hypertrophy, stenosing peptic ulcer, a history of bronchial asthma, hypertension, or cardiovascular disease.

What should I know about interactions with other medicines?

Viscodril Interactions with other medicines and products

Viscodril may interact with other medicines, which can potentially alter its effectiveness or increase the risk of side effects. It is important to inform a healthcare professional about all current medications, including over-the-counter products, supplements, and herbal remedies, before starting this syrup.

Interactions with Medicinal Products:

  • Beta-Blockers: The concurrent use of Viscodril with beta-blocking agents, such as propranolol or atenolol, is generally advised against as it may counteract the bronchodilating effect of the medicine's components.
  • Antidepressants: Specific antidepressants, including tricyclic antidepressants like amitriptyline and desipramine, may interact with Viscodril, necessitating caution and monitoring.
  • Corticosteroids: Use with systemic corticosteroids, such as prednisone, should be undertaken cautiously as the combination may lead to an increased risk of specific adverse effects, particularly hypokalemia (low potassium levels).
  • Diuretics: Taking Viscodril with diuretics, such as furosemide, may also increase the risk of developing hypokalemia.
  • Other Cough Medicines: Concomitant use with other cough suppressants or products containing similar active ingredients should be avoided to prevent a potential alteration of the drug's effects or an increased concentration of similar agents.
  • Theophylline: This medicine, used for respiratory conditions, may interact with Viscodril, potentially altering its effect or increasing the likelihood of adverse events.

Interactions with Products:

  • Alcohol: Consumption of alcohol while taking this medicine may increase effects like dizziness or drowsiness.

Patients with pre-existing conditions like diabetes, cardiovascular diseases, or an overactive thyroid gland may require closer medical monitoring due to the potential for the medicine to impact blood sugar levels, heart rate, or blood pressure.

Mechanism of Action

Targeting Specific Receptor and Enzyme Systems

Viscodril functions as a selective modulator

engaging specific receptor or enzyme systems. This targeted molecular binding alters the activity state of key molecular targets, initiating a change in cellular signaling dynamics. This interaction determines the primary biochemical effect on the cell.

Altering Signal Transduction Cascades

The initial binding leads to intervention within defined signal transduction cascades, where the compound modifies the signaling sequence, altering the propagation of cellular signals. This mechanistic cascade operates in systems characterized by altered pathway activation, modifying the sequence of molecular steps that transmit signals.

️ Influencing Central and Peripheral Pathway Dynamics

The combined pathway effects result in altered signaling dynamics within specified central or peripheral pathways. This modulation influences subsequent molecular output, which defines the compound's profile of physiological adjustments within the targeted biological system.

Dosage and Administration Information

How to Use Viscodril

Viscodril is an oral solution or syrup containing Diphenhydramine and Ammonium Chloride, and its use follows established administration routes, dosage limits, and schedules. The medication is administered exclusively via the oral route for short-term symptomatic use.


Standard Administration Protocols

The established posology (dosing rules) provides defined volumes for administration and sets strict limits on frequency and total daily intake.

Instruction Official Guideline
Route of Administration Oral solution taken by mouth.
Adult/Adolescent Dose 5 mL to 10 mL per dose for individuals 12 years and older.
Dosing Frequency Repeat administration is set at every 4 hours.
Maximum Daily Limit The total intake must not exceed 4 doses in any 24-hour period.
Age Restriction Not suitable for administration to children under 6 years of age.

Procedural Requirements

Accurate administration is essential due to the liquid form. Each dose must be precisely measured using a calibrated dosing device to ensure the correct volume is taken. The medicine is designated for short-term use only, and its schedule may be adapted for nighttime administration, with a specific dose at bedtime followed by subsequent doses every 6 hours if necessary. If a dose is missed, it should only be taken immediately if the delay is no more than one hour; otherwise, the dose must be skipped, and the schedule should be resumed at the next interval.


Recent Clinical Evidence

Research Evidence / Overview of Studies for Viscodril

The clinical evaluation for Viscodril, which contains Diphenhydramine and Ammonium Chloride, has primarily focused on its use for short-term symptom management. This research is important for understanding what has been observed in study settings and where gaps in the evidence still exist.


Research Focused on Acute Cough and Congestion

Research has been applied in studies examining patient-reported experiences during acute or disruptive episodes of upper respiratory illnesses, such as the common cold. Research has explored how symptoms change over time in these situations. The research structure includes short-term Randomized Controlled Trials (RCTs) and systematic reviews.

Researchers monitored several patient-reported outcomes describing perceived discomfort. These included the change in how severe the cough felt and whether coughing was disruptive to sleep. Short-term trials report how symptoms evolved in the observed populations over follow-up durations typically lasting less than seven days.

Findings across studies have shown variability. Some trials described patterns related to changes in cough frequency; however, the degree of change observed in subjective cough severity has varied across trials. Therefore, the evidence contributes to the broader evidence landscape but highlights where results may vary.


Studies of the Component Ingredients

Diphenhydramine was evaluated in research exploring its association with the cough reflex. Studies examined how this component was associated with cough reflex sensitivity in controlled laboratory settings and clinical trials for acute cough.

Ammonium Chloride was studied in research contexts involving physiological factors of phlegm. The evidence supporting the observed effect of this component is largely derived from established pharmacological principles and older literature. Dedicated modern trials focusing on the unique contribution of Ammonium Chloride in combination are sparse.


Evidence in Specific Patient Populations

The majority of the research for this combination and similar products was observed in the adult population. The results apply only to the populations studied. For children, data are still emerging, and certainty remains low. Most regulatory bodies advise against the use of combination cough and cold medicines in younger children (usually under 12 years of age) due to insufficient data to establish whether it was associated with an observable effect in these groups.

Key Studies & References

  1. FDA Label (Package Insert) for Diphenhydramine HCl Oral Solution

Frequently Asked Questions (FAQ)

Common questions about Viscodril (FAQ)

Q: Is Viscodril for long-term or short-term use?

According to official instructions, Viscodril is strictly designated for short-term use only. It is intended to provide temporary, symptomatic relief for acute cough and congestion. It is not approved for chronic or long-term management strategies.


Q: Is a mild headache or dizziness considered a normal feeling when starting Viscodril?

Official safety information lists dizziness as one of the most frequently documented adverse reactions associated with the use of the medicine. This is a common central nervous system effect associated with one of the active components.


Q: Do official sources list an interaction between Viscodril and alcohol consumption?

Yes. Official regulatory documents explicitly state that the consumption of alcohol while taking the medicine may increase specific side effects. This interaction can intensify effects such as dizziness or drowsiness.


Q: What happens in general if a day of Viscodril treatment is missed?

Regulatory instructions specify a rule for managing a missed dose. If a scheduled dose is missed by more than one hour, the instruction is to skip that dose entirely. The regulatory rule is that the regular dosing schedule is resumed at the next scheduled interval.


Q: Is Viscodril classified as safe to use during pregnancy or while breastfeeding?

The medicine is officially contraindicated (prohibited) for use in nursing mothers due to potential risks. For pregnant individuals, use is not recommended unless a healthcare provider determines it is clearly necessary.


Q: Is the use of Viscodril usually considered a long-term management strategy?

No, the medicine is officially designated for short-term use only. Its purpose is to manage acute symptoms, and it is not intended for chronic or long-term management strategies.


Q: What general information is provided about what should be done if too much Viscodril is accidentally taken?

The official safety profile documents the risk of severe adverse reactions from high doses, which include conditions like metabolic acidosis or ammonia toxicity. The risk profile highlights that severe reactions from high doses necessitate immediate emergency medical attention.


Q: Is Viscodril commonly prescribed to or studied in older adult populations?

The official labeling notes that older adults are more susceptible to frequent adverse effects, such as sedation and low blood pressure (hypotension). Due to these increased risk factors, official labeling specifies that this population warrants specific caution and closer medical monitoring.


Q: Is there official information available regarding Viscodril use in children or adolescents?

Yes, official guidance is available for specific age groups. The medicine is not suitable for children under 6 years, and its use in children aged 6 to 11 years is restricted and subject to specific regulatory guidance regarding appropriate dosing.


Q: How quickly should the therapeutic effects of Viscodril be noticed?

Studies related to the Diphenhydramine component indicate that its maximum activity typically occurs in approximately one hour after a single oral dose.


Q: What is the expected time frame for a typical course of treatment with Viscodril?

The medication is intended for short-term symptomatic use only. Clinical trial research supporting its use typically monitors changes over follow-up durations of less than seven days.


Q: Are there specific times of day that Viscodril is generally taken or recommended?

The dosing schedule may be specifically adapted for nighttime administration, often taken at bedtime. This is due to the component's potential for causing sedation or sleepiness, which can be useful for nighttime symptom relief.


Q: Has Viscodril been approved for use in countries outside of the United States?

Yes, this medicine has been approved for use by regulatory bodies outside the United States. Approval is evidenced by the existence of official documents from authorities such as the Rwanda FDA.


Q: Does Viscodril affect blood sugar levels or pose a risk for people with diabetes?

Official safety information notes that the medicine has the potential to impact blood sugar levels. For this reason, official information indicates that patients with pre-existing conditions like diabetes warrant closer medical monitoring.


Q: Can the Viscodril tablet or capsule be crushed, split, or chewed?

The official form of Viscodril is an oral solution or syrup. This liquid must be precisely measured using a calibrated dosing device to ensure the correct volume is taken. Since the medicine is an oral solution, it must be precisely measured using a calibrated dosing device.


Q: Is Viscodril available for purchase without a prescription in some locations?

Yes, one of the active components, Diphenhydramine, is widely available as an over-the-counter (OTC) medication. Its status may vary depending on local regulatory guidelines.


Q: Is Viscodril classified as a narcotic or controlled substance?

The medicine is generally not classified as a scheduled narcotic or controlled substance. Specifically, it is not listed under the US Controlled Substances Act (CSA) and is widely available over-the-counter.


Q: Does Viscodril have an expiration date?

Yes, official labeling requires the product to carry a specific expiration date. This date is typically located on the bottom of the container or on the outer packaging.


Q: Do official warnings state that taking Viscodril makes certain activities, like driving, unsafe?

Official regulatory warnings caution against engaging in activities requiring mental alertness, such as driving a car or operating heavy machinery. This is due to the potential for central nervous system effects like drowsiness and disturbed coordination.


Q: Is there a commonly available generic version of Viscodril?

Yes, the components of Viscodril are available in various syrups and solutions marketed under their generic names, which are Diphenhydramine and Ammonium Chloride. These are produced by different manufacturers.


Q: What are the signs of an allergic reaction to Viscodril?

Official safety information lists a rare but serious adverse reaction called anaphylactic shock. General signs associated with allergic reactions can include symptoms such as itching, skin rash, or hives.


Q: What is the mechanism of action of Viscodril's two components?

The medicine is a combination product where the two active ingredients work together. Diphenhydramine acts primarily as a cough suppressant, while Ammonium Chloride functions as an expectorant to help loosen and clear mucus from the airways.

How should Viscodril be stored and disposed of?

How to Store and Dispose of Viscodril

Official regulatory documents define specific storage and disposal requirements to maintain the stability and safety of Viscodril Syrup.

Storage Conditions

Viscodril must be stored at a temperature not exceeding 30 C. The medicine requires protection from both light and heat and should be kept in a cool and dry place. It is essential to keep the container tightly closed and store the syrup in its original container.

For safety, the product must be kept out of the sight and reach of children.

Disposal Instructions

Unused or expired Viscodril must be disposed of according to the instructions on the product label or as directed by local pharmaceutical waste regulations. Avoid discarding the medicine into household trash or wastewater unless prepared according to official government guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Viscodril found in:

A-Z Index: